找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Rheumatoid Arthritis; The Treatment Contro David H. Goddard,Robin C. Butler Textbook 1984Latest edition Macmillan Publishers Limited 1984 A

[復制鏈接]
11#
發(fā)表于 2025-3-23 11:04:58 | 只看該作者
The need for disease-modifying drugsre potentially toxic. Studies to date have indicated that only a small percentage of patients starting treatment with disease-modifying drugs may derive long-term benefit. A high percentage of patients drop out because of adverse reactions. When analysed in terms of cost versus benefit these treatments may be neither effective nor efficient.
12#
發(fā)表于 2025-3-23 14:41:38 | 只看該作者
Gold in the treatment of rheumatoid arthritise achieved at a high price in terms of toxicity; even when long-term treatment is attempted, only a minority of patients will remain on treatment after three years. The place of gold salts in the treatment of rheumatoid arthritis needs to be reassessed.
13#
發(fā)表于 2025-3-23 19:17:55 | 只看該作者
The need for disease-modifying drugsThis is because there is difficulty in determining which parameters accurately reflect disease activity and disease progression. The Stanford health assessment questionnaire, together with newer radiological techniques, may provide the means by which these assessments can be made..These treatments a
14#
發(fā)表于 2025-3-23 23:02:23 | 只看該作者
Gold in the treatment of rheumatoid arthritis reduce symptoms and signs of synovitis and improve patient well-being to a greater extent than placebo. This advantage will persist for one year after injections have been stopped, but can no longer be demonstrated after a further year. There is no compelling evidence that treatment for longer than
15#
發(fā)表于 2025-3-24 03:36:49 | 只看該作者
16#
發(fā)表于 2025-3-24 08:08:33 | 只看該作者
17#
發(fā)表于 2025-3-24 12:19:18 | 只看該作者
Immunosuppressive therapy for rheumatoid arthritisophos-phamide and chlorambucil (alkylating agents), azathioprine (purine analogue) and methotrexate (folic acid analogue). A Medline search and review articles were used to identify clinical trials of these drugs in patients with rheumatoid arthritis. A scoring system was used to assess the design a
18#
發(fā)表于 2025-3-24 17:37:55 | 只看該作者
19#
發(fā)表于 2025-3-24 20:13:59 | 只看該作者
Conclusionspants, one and all, prescribe one or more of these agents almost every working day of their lives, yet the use of these drugs remains highly controversial. How they should be used — indeed, whether some of them should be prescribed at all — and what studies we should be planning to answer these ques
20#
發(fā)表于 2025-3-24 23:28:43 | 只看該作者
Macmillan Publishers Limited 1984
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-30 05:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
高阳县| 武宣县| 兰溪市| 元阳县| 长乐市| 大洼县| 双桥区| 临西县| 长武县| 武功县| 司法| 连山| 武强县| 郴州市| 津南区| 科技| 横山县| 阳山县| 灌南县| 定州市| 蒙自县| 博罗县| 兰西县| 兴隆县| 巨鹿县| 余姚市| 南昌县| 垣曲县| 那坡县| 五大连池市| 隆子县| 柳江县| 平定县| 济宁市| 土默特右旗| 宽城| 茶陵县| 始兴县| 堆龙德庆县| 水城县| 南和县|